| EGFR Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy JG Paez, PA Janne, JC Lee, S Tracy, H Greulich, S Gabriel, P Herman, ... Science 304 (5676), 1497-1500, 2004 | 12188 | 2004 |
| EGFR Mutation and Resistance of Non–Small-Cell Lung Cancer to Gefitinib S Kobayashi, TJ Boggon, T Dayaram, PA Jänne, O Kocher, M Meyerson, ... New England Journal of Medicine 352 (8), 786-792, 2005 | 4880 | 2005 |
| Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis RL Levine, M Wadleigh, J Cools, BL Ebert, G Wernig, BJP Huntly, ... Cancer cell 7 (4), 387-397, 2005 | 3925 | 2005 |
| The T790M mutation in EGFR kinase causes drug resistance by increasing the affinity for ATP CH Yun, KE Mengwasser, AV Toms, MS Woo, H Greulich, KK Wong, ... Proceedings of the National Academy of Sciences 105 (6), 2070-2075, 2008 | 2357 | 2008 |
| Three-dimensional structure of the tyrosine kinase c-Src W Xu, SC Harrison, MJ Eck Nature 385 (6617), 595-602, 1997 | 1897 | 1997 |
| Structures of lung cancer-derived EGFR mutants and inhibitor complexes: mechanism of activation and insights into differential inhibitor sensitivity CH Yun, TJ Boggon, Y Li, MS Woo, H Greulich, M Meyerson, MJ Eck Cancer cell 11 (3), 217-227, 2007 | 1289 | 2007 |
| Novel mutant-selective EGFR kinase inhibitors against EGFR T790M W Zhou, D Ercan, L Chen, CH Yun, D Li, M Capelletti, AB Cortot, ... Nature 462 (7276), 1070-1074, 2009 | 1211 | 2009 |
| Catalytic specificity of protein-tyrosine kinases is critical for selective signalling Z Songyang, KL Carraway III, MJ Eck, SC Harrison, RA Feldman, ... Nature 373 (6514), 536-539, 1995 | 1172 | 1995 |
| Crystal structure of the tyrosine phosphatase SHP-2 P Hof, S Pluskey, S Dhe-Paganon, MJ Eck, SE Shoelson Cell 92 (4), 441-450, 1998 | 1159 | 1998 |
| Crystal structures of c-Src reveal features of its autoinhibitory mechanism W Xu, A Doshi, M Lei, MJ Eck, SC Harrison Molecular cell 3 (5), 629-638, 1999 | 1134 | 1999 |
| Mechanism and function of formins in the control of actin assembly BL Goode, MJ Eck Annu. Rev. Biochem. 76 (1), 593-627, 2007 | 1081 | 2007 |
| Structure and regulation of Src family kinases TJ Boggon, MJ Eck Oncogene 23 (48), 7918-7927, 2004 | 942 | 2004 |
| The structure of tumor necrosis factor-α at 2.6 Å resolution: Implications for receptor binding MJ Eck, SR Sprang Journal of Biological Chemistry 264 (29), 17595-17605, 1989 | 939 | 1989 |
| Overcoming EGFR (T790M) and EGFR (C797S) resistance with mutant-selective allosteric inhibitors Y Jia, CH Yun, E Park, D Ercan, M Manuia, J Juarez, C Xu, K Rhee, ... Nature 534 (7605), 129-132, 2016 | 863 | 2016 |
| Structure of PAK1 in an autoinhibited conformation reveals a multistage activation switch M Lei, W Lu, W Meng, MC Parrini, MJ Eck, BJ Mayer, SC Harrison Cell 102 (3), 387-397, 2000 | 686 | 2000 |
| Recognition of a high-affinity phosphotyrosyl peptide by the Src homology-2 domain of p56lck MJ Eck, SE Shoelson, SC Harrison Nature 362 (6415), 87-91, 1993 | 650 | 1993 |
| Small molecule blockade of transcriptional coactivation of the hypoxia-inducible factor pathway AL Kung, SD Zabludoff, DS France, SJ Freedman, EA Tanner, A Vieira, ... Cancer cell 6 (1), 33-43, 2004 | 630 | 2004 |
| Structural basis for recruitment of CBP/p300 by hypoxia-inducible factor-1α SJ Freedman, ZYJ Sun, F Poy, AL Kung, DM Livingston, G Wagner, ... Proceedings of the National Academy of Sciences 99 (8), 5367-5372, 2002 | 610 | 2002 |
| Structural, biochemical, and clinical characterization of epidermal growth factor receptor (EGFR) exon 20 insertion mutations in lung cancer H Yasuda, E Park, CH Yun, NJ Sng, AR Lucena-Araujo, WL Yeo, ... Science translational medicine 5 (216), 216ra177-216ra177, 2013 | 603 | 2013 |
| Mutations in the DDR2 Kinase Gene Identify a Novel Therapeutic Target in Squamous Cell Lung Cancer PS Hammerman, ML Sos, AH Ramos, C Xu, A Dutt, W Zhou, LE Brace, ... Cancer discovery 1 (1), 78-89, 2011 | 597 | 2011 |
